Companies: 10,795·Total market cap: $144.5T
Avant Brands Inc.

Avant Brands Inc.

AVNT.TOTSXHealthcare● Active
$0.60
+$0.00(+0.00%)
Market Cap$6835051
P/E Ratio
52W High$1.08
52W Low$0.48

Avant Brands Inc. (AVNT.TO) PE Ratio — Current & Historical Data

Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.

avnt.to · pe ratio · data through Nov 30, 2025

Core PE Ratio Metrics

Trailing 12 months · TTM

The price-to-earnings (P/E) ratio for Avant Brands Inc. (AVNT.TO) measures how much investors pay for each dollar of the company's trailing earnings. AVNT.TO's current PE ratio of N/A is calculated by dividing its stock price of $0.60 by its TTM earnings per share of -$1.09.

N/A
P/E Ratio (TTM)N/A — Company is not profitable (TTM)

Source: FMP · /ratios-ttm · /analyst-estimates · 2025-11-30

Forward P/E
0.18x
FY2027 est. EPS $3.30
Based on 1 analyst
EPS (TTM)
-$1.09
TTM · diluted EPS
PEG Ratio
-0.02
Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Avant Brands Inc. SEC 10-K & 10-Q filings · US GAAPUpdated: 2026-06-08

PE Ratio History

2012 – 2025 · Annual
PE Ratio (TTM)
5Y Avg 112.7x
EPS (Annual)

▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)

PE Ratio vs Peers

Drug Manufacturers - Specialty & Generic · 6 peers · Annual PE
CompanyMarket CapPE (Annual)vs AvgEPS (TTM)
Avant Brands Inc.
Avant Brands Inc.You
AVNT.TO
$7MN/A-$1.09
Ayurcann Holdings Corp.
Ayurcann Holdings Corp.
AYUR.CN
$2MN/A-$0.02
CanadaBis Capital Inc.
CanadaBis Capital Inc.
CANB.V
$2MN/A-$0.01
CLS Holdings USA, Inc.
CLS Holdings USA, Inc.
CLSH.CN
$8MN/A-$0.05
Crescita Therapeutics Inc.
Crescita Therapeutics Inc.
CTX.TO
$15MN/A-$0.00
Lobe Sciences Ltd.
Lobe Sciences Ltd.
LOBE.CN
$22MN/A-$0.03
Mercanto Holdings Inc.
Mercanto Holdings Inc.
MUSH.V
$6MN/A-$0.01

* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio

Annual PE Ratio History

Showing 10 of 14 years
Fiscal Year EndPE RatioEPS (TTM)YoY ChangePE vs Max
2025-11-30Latest
FY2025
$-0.88
2024-11-30
FY2024
$-2.30
2023-11-30
FY2023
$-0.61
2022-11-30
FY2022
$-1.12
2021-11-30
FY2021
$-1.83
2020-11-30
FY2020
$-2.27
2019-11-30
FY2019
$-2.85
2018-11-30
FY2018
$-4.14
2017-12-31
FY2017
$-3.73
2016-12-31
FY2016
$-1.41

▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API

About PE Ratio & Methodology

The price-to-earnings (P/E) ratio for Avant Brands Inc. (AVNT.TO) measures how much investors pay for each dollar of the company's trailing earnings. AVNT.TO's current PE ratio of N/A is calculated by dividing its stock price of $0.60 by its TTM earnings per share of -$1.09.

PE Ratio = Stock Price ÷ EPS (TTM)
= $0.60 ÷ -$1.09 = N/A
TTMTrailing Twelve Months — sum of the most recent 4 quarterly EPS figures
Forward PEStock price ÷ analyst consensus EPS estimate for the next fiscal year
PEGPE ÷ earnings growth rate — values below 1.0 suggest growth may justify the premium
Figures tie to SEC 10-K/10-Q and FMP ratio endpoints where noted.

Frequently asked questions

AVNT.TO pe ratio · 6 questions

AVNT.TO's current PE ratio is N/A as of 2026-06-08, based on a stock price of $0.60 and TTM EPS of -$1.09. Data sourced from Financial Modeling Prep via AVNT.TO's SEC 10-K and 10-Q filings.

AVNT.TO PE ratioWhat is AVNT.TO PE ratioCurrent PE ratio of AVNT.TOAVNT.TO PE ratio today

Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Avant Brands Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-08